Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Levitee Labs Inc. Regulatory Filings 2021

Jul 10, 2021

48029_rns_2021-07-09_dcd910e8-b236-40d3-8076-d9b2eba083f3.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

POOLING AGREEMENT

This document is dated for reference as of July 8, 2021 and references an arrangement

AMONG:

LEVITEE LABS INC. , a company incorporated pursuant to the laws of British Columbia and with a registered office at 6th Floor, 905 West Pender Street, Vancouver, BC, V6C 1L6

(the “ Issuer ”)

AND:

THOSE SHAREHOLDERS OF LEVITEE LABS INC. set forth as Schedule “A” hereto

(each, a “ Shareholder ” and, collectively, the “ Shareholders ”)

WHEREAS:

  • A. Pursuant to the subscription agreements through which the Shareholders subscribed for common shares of the Issuer listed next their names in Schedule “A” (collectively, the “ Shares ”), the Shareholders agreed to pool the Shares upon the closing of the Issuer’s listing on the Canadian Securities Exchange (the “ Listing Date ”) on the terms and conditions as set forth herein; and

  • B. This document evidences the foregoing pooling arrangement to which the Shares are pooled.

1. Placement of Shares in Pool

  • 1.1 The Shares will be released from pooling as follows:
Release Date Percentage of Shares Released from Pooling
6 months from Listing Date 100%

1.2 Legends will be placed on the Shares so as to give effect to the pooling of the Shares contemplated hereby.

2. Voting of Shares in Pool

  • 2.1 The Shareholders may exercise all voting rights attached to the Shares held by them.

3. Waiver of Shareholder’s Rights

3.1 The Shareholders waive no rights attached to the Shares held by them, except the right to sell or otherwise transfer the Shares while they are pooled.

  • 2 -

The Issuer has executed and delivered this document as of the date first referenced above, as evidence of the arrangement described herein.

LEVITEE LABS INC.

Per: /s/ Pouya Farmand Authorized Signatory

SCHEDULE “A”

SHARES SUBJECT TO POOLING

Name of Shareholder Number of Shares
Aadam Tejpar 50,000
Alexander Buev 40,000
Alexander Case 250,000
Alexander Yagnatiev 50,000
Anahita Mafibalani 100,000
Anthony Max Kevin Mar 30,000
Birmingham Consulting Ltd. 100,000
Brent Hogarth 100,000
Brigitte Robinson 50,000
C.C. Investments Ltd. 300,000
Derek De Giovanni 75,000
Deven Bhatt 50,000
Dr. Peter Channan Medical
Professional Corporation
100,000
Evergreen Holding Company Ltd. 500,000
  • 4 -
Ghahary Consulting Services Inc. 200,000
JLS Services, LLC 100,000
Kaviraj Pooni 50,000
Kyle Haddow 100,000
Magic Rahmati 50,000
Mahyar Gaeni 50,000
Marcie Mezzarobba 100,000
Marko Ferenc 75,000
Miguel de Sousa 25,000
Nicole Vicente 50,000
Parisa Farmand 50,000
Randy Hildebrandt 100,000
Ron Segev 100,000
Roxana Sarvghad Moghadam 100,000
Saeid Ansari 200,000
Semida Viseroiu 75,000
Shahin Behroyan 50,000
  • 5 -
Shayan sepehripour 50,000
Siavash Ashrafinia 150,000
Simintadj Badr 50,000
Sofia Capital Corp. 100,000
Sohrab Mehregani (Canaccord acc:
20J258A1)
50,000
Soroush Ansari 100,000
Steven Sugrim 50,000
Thomas & Brenda Haddow 100,000
Vladimir Zadorojnyi 50,000
Vortep Kasi Holdings Inc. 500,000
Yvette Sheppard 20,000
Zahra Forghani 50,000
TOTAL 4,540,000